Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.30
    OpenPayerBilling CodesFactors Influencing Health Status and Other Contacts with Health ServicesDRG 948-signs-and-symptoms-without-mcc
    Ask Trek AI about this page

    Signs and Symptoms without MCC: Inpatient Reimbursement Overview

    DRG 948 encompasses inpatient admissions for nonspecific signs and symptoms without a Major Complication or Comorbidity or Complication or Comorbidity, representing lower-acuity clinical presentations such as generalized weakness or unspecified pain. This matters for inpatient reimbursement because payments under this Diagnosis-Related Group are generally lower than for specific-diagnosis groups, affecting hospital revenue, case-mix reporting, and resource allocation for evaluation and observation.

    Customize your policy alerts

    Sign up for drg 948 policy alerts

    Get alerted when payer policies referencing 948 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    DRG 948 Overview

    DRG 948 covers inpatient cases coded primarily for signs and symptoms without a Major Complication or Comorbidity and without a Complication or Comorbidity, typically including nonspecific presentations such as generalized weakness, abdominal pain, chest symptoms, or other vague complaints that do not resolve into a specific, higher-weighted diagnosis. This Diagnosis-Related Group is important for Medicare payment because it groups lower-acuity admissions that still require inpatient resources for evaluation, monitoring, and symptomatic treatment. Reimbursement under this Diagnosis-Related Group reflects lower relative weights compared with diagnosis-driven groups, influencing hospital case-mix index and payment for short-stay or observational inpatient encounters.

    Table of contents

    Progress1 / 3

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • Facility ComparisonBeds, revenue & payer mix
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical Trials

    • Acute diagnostic and early management studies: Trials focused on rapid diagnostic pathways and early management strategies for patients admitted with non-specific signs and symptoms (e.g., syncope, chest pain with non-diagnostic ECG, fever of unknown origin). These studies enroll adults presenting to the emergency department or inpatient wards where an immediate diagnostic dilemma exists, testing protocols such as accelerated imaging algorithms, standardized observation-unit pathways, or biomarker-driven triage to reduce unnecessary admissions. Results are relevant to providers and payers because improved early diagnosis can reduce inpatient length of stay, avoid costly downstream testing, and decrease preventable resource use within this DRG.
    • Comparative effectiveness and care-process trials during the index hospitalization: Research comparing different inpatient management approaches for symptom-based presentations without major complications — for example, randomized or pragmatic studies of structured clinical observation versus routine admission, or of multidisciplinary consult-led evaluation versus usual care. These trials target heterogeneous hospitalized adults whose principal diagnosis is a sign or symptom rather than a definitive disease, and they evaluate outcomes such as diagnostic yield, time to definitive diagnosis, complication rates, and hospital costs. Findings inform clinicians and payers about which care processes safely optimize diagnostic efficiency and resource utilization for this common DRG population.
    • Post-discharge outcomes and transitional-care studies: Prospective cohort studies and intervention trials examining post-discharge trajectories, readmission risk, and outpatient follow-up models for patients discharged with symptom-based diagnoses (for example, outcomes of structured outpatient rapid-access clinics, telehealth follow-up, or targeted case management). These studies focus on preventing readmissions, identifying delayed diagnoses, and measuring patient-reported outcomes and healthcare utilization in the weeks to months after discharge. Results are pertinent to providers and payers because effective transitional care can reduce costly readmissions and improve value for patients whose initial inpatient episode is coded under this DRG.

    Related Codes

    939-O-R-PROCEDURES-WITH-DIAGNOSES-OF-OTHER-CONTACT-WITH-HEALTH-SERVICES-WITH-MCC

    O.R. Procedures with Diagnoses of Other Contact with Health Services with MCC: Inpatient Reimbursement Overview

    940-O-R-PROCEDURES-WITH-DIAGNOSES-OF-OTHER-CONTACT-WITH-HEALTH-SERVICES-WITH-CC

    O.R. Procedures with Diagnoses of Other Contact with Health Services with CC: Inpatient Reimbursement Overview

    941-O-R-PROCEDURES-WITH-DIAGNOSES-OF-OTHER-CONTACT-WITH-HEALTH-SERVICES-WITHOUT-CC-MCC

    O.R. Procedures with Diagnoses of Other Contact with Health Services without CC/MCC: Inpatient Reimbursement Overview

    945-REHABILITATION-WITH-CC-MCC

    Rehabilitation with CC/MCC: Inpatient Reimbursement Overview

    946-REHABILITATION-WITHOUT-CC-MCC

    Rehabilitation without CC/MCC: Inpatient Reimbursement Overview

    947-SIGNS-AND-SYMPTOMS-WITH-MCC

    Signs and Symptoms with Major Complication or Comorbidity: Inpatient Reimbursement Overview

    949-AFTERCARE-WITH-CC-MCC

    Aftercare with CC/MCC: Inpatient Reimbursement Overview

    950-AFTERCARE-WITHOUT-CC-MCC

    Aftercare without CC/MCC: Inpatient Reimbursement Overview

    951-OTHER-FACTORS-INFLUENCING-HEALTH-STATUS

    Other Factors Influencing Health Status: Inpatient Reimbursement Overview

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.